However, in preclinical models, similar results also demonstrated that NRP1 removal led to higher cell proliferation [42] and lower cell migration, invasion [40,42,53], epithelial-to-mesenchymal transition (EMT) [40] and angiogenesis [53] in cervical cancer [42], NSCLC [53] and gastric cancer [40]. This evidence concerns the gene NRP1 and cervical cancer.